CoGenesys

CoGenesys raises $55 million in Series A financing

Published in Lab Business Week, July 16th, 2006

CoGenesys, Inc. announced the completion of a $55 million Series A financing, which will be used to advance the company's pipeline of product candidates entering clinical-stage development.

The financing was led by New Enterprise Associates (NEA) with additional investments by OrbiMed Advisors and Red Abbey Venture Partners and a significant equity participation by Human Genome Sciences, Inc. (HGSI). Founded by former senior executives of HGS, CoGenesys is advancing a broad pipeline of improved, long-acting biopharmaceuticals developed to address unmet medical needs across a broad spectrum of therapeutic areas.

Craig A. Rosen, PhD, CoGenesys'...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-07-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry